Bloomage Biotechnology Corp

Bloomage Biotechnology Corp FCF Conversion

The FCF Conversion Rate (FCF/EBITDA) of Bloomage Biotechnology Corp (688363.SS) as of Oct 30, 2026 is 103.33 %. In the previous year, FCF Conversion Rate (FCF/EBITDA) was -90.02 % — a change of -214.78% (higher).

FCF Conversion

103.33 %

YoY

-214.78%

Last updated:

FCF Conversion Rate (FCF/EBITDA) of Bloomage Biotechnology Corp is 2025 103.33 % . FCF Conversion Rate (FCF/EBITDA) of Bloomage Biotechnology Corp was 2024 -90.02 % . It decreases by -214.78% higher compared to the previous year.

The Bloomage Biotechnology Corp FCF Conversion history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF Conversion
Date
FCF Conversion
Jan 1, 2018
64.62 CNY
Jan 1, 2019
-14.57 CNY
Jan 1, 2020
-8.93 CNY
Jan 1, 2021
62.87 CNY
Jan 1, 2022
-6.31 CNY
Jan 1, 2023
-55.81 CNY
Jan 1, 2024
-90.02 CNY
Jan 1, 2025
103.33 CNY
The Bloomage Biotechnology Corp FCF Conversion history
YEARFCF ConversionYoY
103.33 %-214.78%
-90.02 %+61.32%
-55.81 %+785.03%
-6.31 %-110.03%
62.87 %-804.26%
-8.93 %-38.74%
-14.57 %-122.55%
64.62 %-51.71%
133.81 %+62.57%
82.31 %-229.18%
-63.71 %-642.78%
11.74 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Bloomage Biotechnology Corp Stock analysis

What does Bloomage Biotechnology Corp do? Bloomage Biotechnology Corp. Ltd. generates revenue through the production and sale of hyaluronic acid, sodium hyaluronate bulk drugs, and medical supplements via fermentation. The company's product portfolio includes raw material products featuring bioactive compounds centered on hyaluronic acid, used across pharmaceuticals, medical devices, cosmetics, functional food, and general food sectors. Medical end products target medical beauty and medicine segments with offerings like ophthalmic viscoelastics, medical lubricants, soft tissue fillers, and medical skin protectors. Functional skin care products consist of lotions, creams, facial masks, and hand masks, while functional foods include hyaluronic acid water and hyaluronic acid food. The company serves pharmaceutical manufacturers, cosmetic brands, and food producers seeking hyaluronic acid-based solutions. The firm's raw material products form the core of its business, supplying bioactive ingredients for diverse industries. Medical end products cater to healthcare providers and clinics specializing in aesthetic procedures and medical treatments. Functional skin care products are sold to cosmetic retailers and e-commerce platforms, while functional foods target health-conscious consumers through food and beverage companies. All products are distributed through established channels without mentioning specific partners or distributors. Bloomage Biotechnology's revenue streams are directly tied to the demand for hyaluronic acid across multiple applications. The company's fermentation-based production method enables cost-effective manufacturing of high-quality raw materials and end products. Its product range spans from bulk pharmaceutical ingredients to consumer-facing items, allowing it to capture value across the entire supply chain from ingredient suppliers to final consumers. Bloomage Biotechnology Corp is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Bloomage Biotechnology Corp stock

FCF Conversion Rate (FCF/EBITDA) of Bloomage Biotechnology Corp is 103.33 % in 2025.

FCF Conversion Rate (FCF/EBITDA) of Bloomage Biotechnology Corp changed from -90.02 % to 103.33 %, representing a -214.78% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of FCF Conversion Rate (FCF/EBITDA) Bloomage Biotechnology Corp since 2006 – with annual values, charts, and detailed analysis.

FCF conversion measures how effectively EBITDA converts to free cash flow. Higher conversion indicates efficient capital allocation and low maintenance costs.

A 'good' varies by industry and company stage. On Eulerpool, you can compare FCF Conversion Rate (FCF/EBITDA)'s Bloomage Biotechnology Corp with sector peers and the industry average to assess whether it is attractive.

To evaluate FCF Conversion Rate (FCF/EBITDA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for FCF Conversion Rate (FCF/EBITDA).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Bloomage Biotechnology Corp

All Key Metrics — Bloomage Biotechnology Corp